{"id":225821,"title":"VICH guideline 52: Bioequivalence - Blood Level Bioequivalence Study (step 4) - 2014 Health Canada Consultation Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T16:20:39.794000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/veterinary-drugs/consultations/vich-guideline-52-bioequivalence-blood-level-bioequivalence-study-step-4-consultation-notice.html","snippet":"VICH guideline 52: Bioequivalence - Blood Level Bioequivalence Study (step 4) - 2014 Health Canada Consultation Notice - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search Canada.ca…","rawSnapshotUrl":"/api/snapshots/raw/225821","browseUrl":"https://replay.healtharchive.ca/job-1/20250418162039/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/veterinary-drugs/consultations/vich-guideline-52-bioequivalence-blood-level-bioequivalence-study-step-4-consultation-notice.html#ha_snapshot=225821","mimeType":"text/html","statusCode":200}